000			03343nam a2200421 i 4500
999			_c112730 _d112730
001			112730
003			ES-MaUEC
005			20230223093937.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			181206s2019 gw a o |||| 0|eng d
020			_a9783030035020
024	7		_a10.1007/978-3-030-03502-0 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC268.5 _b2019 EB
245	0	0	_aHIV/AIDS-Associated Viral Oncogenesis _cedited by Craig Meyers
250			_a2nd ed. 2019
264		1	_aCham _bSpringer International Publishing _c2019
300			_a1 recurso en línea (VIII, 250 páginas) _b17 ilustraciones, 10 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aCancer Treatment and Research _x0927-3042 _v177
490	0		_aMedicine (Springer-11650)
505	0		_aOverview -- HIVAIDS Malignancies -- Molecular Biology of KSHV in Relation to HIV/AIDS - Associated Oncogenesis -- KSHV-Associated Disease in the HIV/AIDS Patient -- Molecular Biology of EBV in Relationship to HIV/AIDS - Associated Oncogenesis -- EBV-Associated Diseases in HIV/AIDS Patient -- HPV-Associated Genital Cancer in the HIV/AIDS Patient -- HPV-Associated Oral Tumors and Cancer in the HIV/AIDS Patient -- HPV-Associated Anal Cancer in the HIV/AIDS Patient -- Merkel Cell Carcinoma in the HIV/AIDS Patient -- Polyomavirus SV40 and AIDS-Related Systemic Non-Hodgkin's Lymphoma -- HIV-HBV and HIV-HCV Coinfection and Liver Cancer.
520	3		_aIn this book, leading experts examine the clinical and biological aspects of viruses known to play a role in the oncogenesis of AIDS-associated cancers and non-AIDS-defining malignancies more commonly observed in HIV-infected individuals. Among the malignancies considered are those associated with Kaposi sarcoma-associated herpesvirus (KSHV) or Epstein-Barr virus (EBV), Merkel cell carcinoma due to Merkel cell polyomavirus (MCPyV), human papillomavirus (HPV)-associated anogenital and oropharyngeal cancers, and hepatitis B and C virus (HBV/HCV)-associated liver cancers. It also provides detailed information on the molecular biology of the causative viral agents and guidance on the specific treatment required in this special population. Covering all the important advances in our understanding made since the first edition was published in 2007, including the discovery and characterization of MCPyV, which brought the number of known human oncoviruses to seven, this new edition is a valuable resource for members of the scientific and healthcare community and active researchers in this field.
988			_aSpringer_Medicine_2019
650		7	_2embne _aCarcinogénesis _9146492
650		7	_2embne _aEnfermedades inmunológicas _9142010
700	1		_aMeyers, Craig. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service) _9106996
776	0	8	_iPrinted edition: _z9783030035013
776	0	8	_iPrinted edition: _z9783030035037
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-03502-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_dz _b02/2023 _eb _zSI